|
Volumn 356, Issue 16, 2007, Pages 1682-1683
|
Persistent coronary occlusion after myocardial infarction [17]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
BETA ADRENERGIC RECEPTOR BLOCKING;
BLOOD CLOT LYSIS;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG USE;
HEART ARRHYTHMIA;
HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HIGH RISK PATIENT;
HUMAN;
LETTER;
LONG TERM CARE;
MORTALITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
CORONARY ARTERY OBSTRUCTION;
NOTE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
DEFIBRILLATOR;
EPIDEMIOLOGY;
QUALITY OF LIFE;
RECURRENT DISEASE;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY STENOSIS;
HUMANS;
MYOCARDIAL INFARCTION;
ARRHYTHMIA;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
DEFIBRILLATORS, IMPLANTABLE;
QUALITY OF LIFE;
RECURRENCE;
|
EID: 34247251946
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (3)
|